1400 SIERRA POINT PARKWAY, BRISBANE, CA
Market cap: $670.9M (2/09/2026)
Price: $5.61
Investor Presentation
Accelerating Next Generation Targeted Immunotherapy Platform for Treatment of Neuroinflammatory Diseases with Multiple Registrational Milestones in 2026
Material Contracts, Other Events
Reports Third Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
Earnings Release
News, Securities Holder Rights or Indentures
Submission of Matters to a Vote of Security Holders
Q3
Q2
Q1
FY 2024
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Free Writing Prospectus